Nice, Weiner expert is in the house. Couple of questions since you're here if you don't mind.

The PR from 7/26 states the purchase of the Teco facility has been closed. How does this affect your opinion on ever getting in a crop?

Are you stating all who involve themselves with Weiner are thieves? How does that go with respect to Leslie Bocskor and Electrum?

Is 2 million shares of a 54mm O/S, considering Ellins owns 15mm and Lazarus owns 10mm, really enough to be called a death spiral financing? Actually, Ellins is giving up part of his portion for the lease option and sleek is a poor source of information.

Why did Woodman Management, Sean Harris and Justin Lee, switch gears? The PLV terms changed and they gave up royalties and buy in rights for equity.

Now that W-Net is the Teco property owner and major investor in the operations of Pacific Leaf, does it not seem like Weiner may actually be building something here other than his past financing tactics?

Chart looks like a break out is coming...

Yep, it's all about the transparency. I don't see them hiding anything.

"and (iii) with respect to our Series B Preferred Stock (and Series Z Preferred Stock if Proposal 4 is not approved) no adjustments would be made to the conversion rate of our Series B Preferred"

Looking forward to your thorough work!

Do you know who these people are?

B team....shit

Just so we're clear:

If this proposal is approved, then, immediately upon the filing of the Certificate of Amendment with the Secretary of State of the State of Nevada, the 21,378 shares of Series Q Preferred Stock currently outstanding will be converted into 106,890,000 shares of Common Stock and the 8,166 shares of Series Z Preferred Stock currently outstanding will be converted into 15,164,262 shares of Series B Preferred Stock.

Meet your new masters:

Miguel Rodriguez(9)
Series Q Preferred Stock
3,420
(2)
16
%
Justin Jarin(9)
Series Q Preferred Stock
3,420
(3)
16
%
Michael Christian Gard(9)
Series Q Preferred Stock
3,420
(4)
16
%
Sewell Woodfork(9)
Series Q Preferred Stock
3,420
(5)
16
%
Michael Nolin(9)
Series Q Preferred Stock
3,420
(6)
16
%
David Kang(9)
Series Q Preferred Stock
1,711
(7)
8
%
Lillian Kang(9)
Series Q Preferred Stock
1,711
(8)
8
%

Hey Mag, hope you are enjoying this nice little run here!

Can any of you fine folks give me the Sq/Ft of Blum Oakland?

It's really unknown at this point what the landscape may be. Here is an opinion from the RJ:

"For example, this is not legalization in the purest sense: Only those who currently have licenses to distribute medical marijuana, or those who run liquor distributorships, will be allowed to grow, test, distribute and sell recreational marijuana. The state Taxation Department will strictly oversee and regulate the marijuana market in Nevada from cultivation to sale, an approach that won’t completely eliminate the black market for the drug."

Things could change as the market develops, but I think things will be locked in for the licensees for awhile.

If NV passes adult use they will create another division under some govt body. Since the measure is to be regulated like alcohol, then one of those possibly. It will also take legislation to form rules and governance, the med license's will be protected for a few years I suspect(see California).

You missed it brother, the pump has already came and gone...at least the first one.

Posted this in June before she went to .44.

http://online.fliphtml5.com/nueh/qrhz/#p=1

Booted the CEO, new board member, grow facility about to start production, world class genetics and now a dispensary for distribution.

What more could a boy need?

I agree, November could be a great month.

Curious if you have a theory of how they will have the RS planned out.

My theory, they are at 950mm shares with the financing that may or may not cover the aquisition, but before they refile the S-3 to access the real money(75mm, there's the golden key) they have to RS it back down to 100mm to make it look good to the legal investors who are waiting. Got nothing to do with Naz...and they best not keep the preferred's shielded, or it will be as On2 says, a freaking penny stock Armageddon.

From the Washington Post:

https://www.washingtonpost.com/graphics/local/md-marijuana/

Hello old friends.

http://online.fliphtml5.com/nueh/qrhz/#p=1

:) Good to see someone making their own decision! Good luck to us all.

Gap in the chart around .26 first of all. I think we test the old resistance line of .18 as new support. I would be happy at .23 if it consolidates there.

Fundamentally, they are worth .05-.06 fully diluted.

Sorry JL, not time for me to go long. I still see some downside left here.

I believe the DEA will part this plant out and remove CBD from schedule 1 to 3. There is already credible research for this determination. They will also move the other cannabinoids to schedule 2 to allow the research to begin, but deny the entourage effect. THC still scares the powers, and they have no clue what the other 378 do, let alone the combinations.

Here's what's going to happen with rescheduling: "This suggests that the DEA is seriously leaning toward to rescheduling at least some cannabinoids, like CBD, for instance, in the interest of spurring research."

Lol, Ageis has these boys jumping!

I think Steve DeAngelo said it best when talking about the regulators,

they won't get the plant unless we give it to them

Moving forward reason? Hiccup?? That's funny.

Sell all your stock (based on a discussion point) are your words, not mine. I don't give a sheet what you all do with your money. Make up your own mind, it's why you have one, sheez...Maybe a puff or two would help that stress level.

"With a prescription-only industry, states would lose their current marijuana-related jobs to existing pill-manufacturing companies."

Doesn't matter the reason, in clinicial trails to prove the effacy of the drug under schedule II, one wrong move, no matter how stupid(and easy) the fix would have been, it's done. TRTC can't afford this scheduling.

I've said all along, someone will step in and DP has been making this pretty!

You get it.

I care how the fools regulate this industry, you should too.

Great trading philosophy otherwise.

Schedule ll will require TRTC to pull all of their brands off the shelves and put them through the regulatory process to be proven a safe drug, including raw materials used, formulation, extraction process and finished product. Going by them recently pulling tainted materials form the shelves already, I don't think they will survive the scrutiny of a FDA trail of 5 years. Selling themselves to Purdue wouldn't be a bad move though...

Speaking of train wrecks, who wants to talk about the audited financials of BOG? No, how about the consignment contractors taking 50% for being good at what they do?? No, how about Kaufman, I never get tired of that guy!

Lol, that's what I was thinking!

Oh yea,

If he doesn't amend the merger agreement to reflect the current valuation vs the "estimated", then consider yourself served.

My concern, Kaufman is #1.

He pulls the strings it seems, original gangster. He has control evidenced by his award in the merger. From his dealings with Rush to his grip on daily operations, security to landlord and whatever else is in the shadows. He has voting power and probably orchestrated the B non-reverse...wouldn't surprise me if he has a cut in the Platinum Asset Management agreement. He approved the Ageis deal to keep the lights on and pay debt off with more debt...good business move for sure. The audit of BOG shows minimal growth, and ineptness in the operations as evidence by the IVXX 'brand' non performance and the use of consignment contractors. He also is probably responsible for having sleek moved to a different facility that doesn't have Internet. This is turning sad, I might need to move on.

Not good folks, this is getting sad.

Who is the shell TRTC?

Ooohhh....Kushman in the home house, now there is a brand worth having.

Randall is a hero.

The Nixon documents are what pisses me off.

http://www.csdp.org/research/nixonpot.txt

Totally disagree with all your statements, except for the franchising of Blum. That has nothing to do with rescheduling.

Schedule II will not allow banking or product being able to cross State lines. In fact, it will make it more difficult for States to conduct business due to the regulations that will come from the Feds on schedule II for research.

Penny stocks use convertables, doesn't cost them anything. 12% on the notes will be better than a bank gives this industry in the first years.

State inspection should be coming soon. Good consolidation going on before that news.

Thank you, that's very interesting. Thanks for the bread crumb on the path of knowledge.